Japanese Pharma Fujisawa Invests in Quark Biotech

genomeweb
360dx

Japanese Pharma Fujisawa Invests in Quark Biotech

Jun 27, 2001

NEW YORK, June 27 - Japanese pharmaceutical company Fujisawa has made an undisclosed equity investment in Quark Biotech (QBI), the companies said Wednesday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Co-Diagnostics Receives CE-IVD Marking for Zika Test
Cancer Genetics, GeneCast Ink Cancer Test Distribution Deal
Danaher Q3 Revenues Rise 7 Percent
Luminex to Pay $75M for MilliporeSigma's Flow Cytometry Research Portfolio
Exact Sciences Acquires Sample Preservation Technology Provider Biomatrica
OpGen Prices $3.2M Stock Offering

The Scan

Microsoft, But the Brain, Too

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

Been Reclassified

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

This Week in Cell

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

Pursuit of a Cancer Vaccine

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Main menu